Stratos Wealth Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Stratos Wealth Partners’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$20K	–	2618
2018 Q3	$20K	Buy	+200	New	+$21.6K	﹤0.01%	1885
2018 Q2	–	Sell	-315	Closed	-$31K	–	2703
2018 Q1	$31K	Buy	315 +31	+11%	+$3.14K	﹤0.01%	1826
2017 Q4	$30K	Buy	+284	New	+$31.2K	﹤0.01%	1764

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Stratos Wealth Partners's TARO Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2018, closing a stake of 200 shares — an estimated $20K sold.

Stratos Wealth Partners first reported a position in TARO in Q4 2017 and held it in 3 quarters. The position peaked at $31K in Q1 2018. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2018.

Stratos Wealth Partners reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2018 after selling out during the quarter.
Stratos Wealth Partners sold 200 Taro Pharmaceutical Industries Ltd. shares in Q4 2018, an estimated $20K.
Stratos Wealth Partners first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2017 and held it in 3 quarters.
Stratos Wealth Partners's Taro Pharmaceutical Industries Ltd. position peaked at $31K in Q1 2018.
94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.